p53 undergoes phosphorylation on several residues in response to cellular stresses that include UV and ionizing radiation, however the in¯uence of spindle damage on this parameter is relatively unclear. Consequently, the eect of nocodazole on serine 392 phosphorylation was examined in two epithelial cell lines. We show that this process is dependent upon the stepwise activation of p38 mitogen-activated protein kinase (p38 MAPK) and protein kinase casein kinase 2 (CK2). Furthermore, this activation correlated with the biochemical regulation of the maturation-promoting factor (MPF, cdc2/cyclin B), as both DRB and antisense depletion of CK2, as well as SB203580 were associated with an inhibition of its activation in response to nocodazole. Strikingly, when the cell cycle characteristics of nocodazole treated cells were examined, we observed that depletion or inhibition of the catalytic subunit of CK2, in the presence of microtubule inhibitors, resulted in a compromise of the G2 arrest (spindle checkpoint). Furthermore, CK2-depleted, nocodazole treated cells demonstrated a dramatic reduction in the apoptotic cell fraction, con®rming that these cells had been endowed with oncogenic properties. These changes were observed in both HeLa cells and HCT116 cells. We also show that this eect is dependent on the presence of functional wild-type p53, as this phenomenon is not apparent in HCT116 p53
Introduction
The tumor suppressor protein p53 possesses a number of anti-oncogenic properties, which include the induction of growth arrest and apoptosis, as well as its ability to block transformation by oncogenes (Finlay et al., 1989; Baker et al., 1990; Yonish-Rouach et al., 1991; Dulic et al., 1994; Miyashita and Reed, 1995;  and reviewed in Levine, 1997) . Additionally, p53 was proposed to be a component of the spindle assembly checkpoint (Cross et al., 1995) , however, subsequent work indicates a role in the post-mitotic checkpoint (Lanni and Jacks, 1998) . Both pieces of evidence suggest an important role for p53 in maintenance of diploidy and DNA integrity.
The structure of p53 comprises four domains (reviewed in Ko and Prives, 1996) . The transcriptional activation domain is situated between amino acids 1 ± 43. The sequence-speci®c DNA-binding domain stretches from amino acid 100 to 300, and is the site most frequently mutated in human tumors. The oligomerization and regulatory domains are located at the C-terminus between 300 ± 393. The mechanism whereby cellular stress is communicated to p53, so that it is functionally activated remains incompletely understood, but likely involves p53 modi®cation by processes such as phosphorylation and acetylation, which stabilize and activate the molecule (Hupp et al., 1992; Gu and Roeder, 1997; Sakaguchi et al., 1998) . A range of dierent protein kinases, that includes c-Jun Nterminal kinase (JNK), p38 MAPK, protein kinase C (PKC), casein kinase 1 (CK1), ATM kinase and DNAdependent protein kinase (DNA-PK), may mediate p53 phosphorylation (reviewed in Prives and Hall, 1999) . The exact roles of some of these molecules remain unclear. DNA-PK phosphorylates residues 15 and 37 of p53, and this appears to aect transactivation and growth arrest in some cells (Lees-Miller et al., 1992; Fiscella et al., 1993) . However, these processes occur normally in cells lacking DNA-PK also, indicating the presence of possible compensatory mechanisms (Huang et al., 1996) . Another important rami®cation of serine 15 phosphorylation by DNA-PK is the reduced interaction of p53 with its negative regulator MDM2 (Haupt et al., 1997; Kubbutat et al., 1997; Shieh et al., 1997) . The same net eect occurs in response to MDM2 phosphorylation by DNA-PK and ATM (Mayo et al., 1997; Khosravi et al., 1999) . Notably, spindle disruption also eects increased serine 15 phosphorylation but this appeared to be dependent on the agent used, and occurred in epithelial cells, but not in primary cultures of human ®broblasts (Stewart et al., 2001) .
Protein kinase CK2 (formerly known as casein kinase II) was ®rst shown to phosphorylate murine p53 at serine 389 (Meek et al., 1990; Herrmann et al., 1991) . Phosphorylation by CK2 has been shown to enhance p53 sequence-speci®c DNA binding in vitro (Hupp et al., 1992) , which in turn contributes to its transactivation function in vitro (Mundt et al., 1997) . In vivo, the phosphorylation of p53 protein at the CK2 site has been reported to regulate p53-speci®c transcriptional repression (Hall et al., 1996) . More recent evidence indicates that rodent cells exposed to UV radiation but not ionizing radiation or etoposide also exhibit increased serine 389 phosphorylation, and that CK2 could phosphorylate the serine 389 site in vitro (Kapoor and Lozano, 1998; Lu et al., 1998) . Further work using a dominant negative mutant of p38 MAPK and the speci®c p38 MAPK inhibitor, SB202190, indicates that this site is phosphorylated by p38 MAPK (Huang et al., 1999) . In contrast to genotoxic stress, it is currently unknown whether the CK2 site is involved in the response to spindle damage.
Protein kinase CK2 is a ubiquitous, second messenger-independent protein serine/threonine kinase which is composed of two catalytic a-or a'-subunits and two regulatory b-subunits (Allende and Allende, 1995; Pinna and Meggio, 1997) . Although its precise biochemical regulation remains unknown, we have demonstrated that CK2 may be activated by p38 MAPK in response to stress, through a direct protein ± protein interaction (Sayed et al., 2000) . Here we report that CK2 is involved in two novel functions in response to spindle damage, both in maintaining G2 arrest and in the subsequent apoptosis process.
Results

Depletion or inhibition of CK2 compromises mitotic arrest
To investigate whether CK2 is required for mitotic checkpoint function, we employed antisense to the alpha subunit to deplete the protein kinase. We transfected HeLa cells with either CK2 (a/a' subunits) antisense (AS) or sense (S) oligodeoxyribonucleotide. The expected depletion of CK2 upon AS oligonucleotide treatment was con®rmed by assaying the intracellular protein level of CK2 a/a' subunits by immunoblotting (Figure 1c ). Previous studies, using the same antisense oligonucleotide, have demonstrated not only complete depletion of the catalytic CK2 a/a' subunits (Ulloa et al., 1993) , but also inhibition of sorting of the regulatory b subunit, preventing its translocation to the nuclei (Ulloa et al., 1994) . Cells were then synchronized at G0 phase and released into the cell cycle, by the addition of serum-containing medium. Nocodazole, a drug that disrupts the mitotic spindle by inhibiting microtubule polymerization, was added before cells entered the mitotic (M) phase. After 9 ± 10 h, microscopic examination of transfected cells with either S oligonucleotide or buer alone revealed that many of them became rounded, indicative of cells arrested in mitosis (Figure 1a) . In contrast, cells transfected with AS showed fewer rounded cells. We then measured the percentage of cells in mitosis (mitotic index, MI) after nocodazole treatment. The average MI of cells with either S-treated or buer was 63% (1008 of 1600 cells), whereas the MI of cells transfected with AS was 11% (176 of 1600) ( Figure  1b) . These results indicated that CK2 depletion was responsible for a reduction in the mitotic cell fraction. However they did not establish whether this occurred before or after cells had arrested in G2/M. Similar results were observed using the CK2 speci®c inhibitor DRB that was added 2 h prior to nocodazole exposure (data not shown).
CK2 functions as a component of the spindle assembly checkpoint
The spindle assembly checkpoint is the mechanism that prevents the onset of anaphase in cells that have defects in spindle assembly or chromosome alignment on the spindle (Li and Nicklas, 1995) . Recently, it has been demonstrated that inhibition of p38 MAPK activity, in response to spindle disruption, compromises the spindle assembly checkpoint (Takenaka et al., 1998) . Based upon our earlier observations that p38 MAPK and CK2 interact directly, we therefore tested whether CK2 might also participate in the spindle assembly checkpoint of the somatic cell cycle. Transfected HeLa cells with S, AS, or left untreated (control) were synchronized at G1/S phase boundary by a double thymidine block and released into the cell cycle. Cells were then either treated with nocodazole for 10 h or released without treatment for 9 h during which the mitotic cells were collected by mechanical shake o. Dramatic increases of maturation-promoting factor (MPF) and p34 cdc2 activities were observed in nocodazole-treated cells, indicative of mitotic arrest (Figure 2a,b) . These activities were substantially suppressed in AS-transfected cells after nocodazole exposure. Thus, the activation of a key component of the mitotic spindle assembly checkpoint induced by the microtubule poison nocodazole was compromised by depletion of CK2. Similar results were obtained after nocodazole exposure in cells pre-treated with the p38 MAPK speci®c inhibitor SB203580.
We next examined whether CK2 was activated in nocodazole-treated cells or in normal M phase. Immune complex kinase assay for CK2 revealed that the activity of CK2 from nocodazole-arrested mitotic cell lysates was four times greater than that from interphase cells (control). Little to no activity of CK2 was observed in mitotic cells (shake-o) and the activity of CK2 by nocodazole was attenuated by inhibition of p38 MAPK using SB203580 (Figure 2c ). Collectively, with the previous studies (Sayed et al., 2000; Takenaka et al., 1998) , we conclude that nocodazole treatment appears to activate p38 MAPK in association with CK2 by disrupting spindle formation.
Nocodazole-induced p53 serine 392 phosphorylation is mediated by CK2 and is SB203580 sensitive
In our previous study we showed that the phosphorylation of p53 at serine 392 induced by stress, was Equal amounts of protein extracts were subjected to protein immunoblot analysis with monoclonal anti-CK2a antibody. Lower mediated by CK2 as a result of direct interaction with p38 MAPK (Sayed et al., 2000) . We reexamined this ®nding in the context of spindle disruption. Figure 2d shows that the hyperphosphorylation of p53 at serine 392 due to nocodazole, was completely suppressed in cells either transfected with AS or treated with p38
Figure 2 (a) Suppression of nocodazole-induced MPF activity by either CK2 antisense or a speci®c inhibitor of p38. HeLa cells were synchronized at G1-S by double thymidine block and either collected (control) or released into cell cycle. After release, the cells were incubated with or without nocodazole (400 ng/ml). In some experiments SB203580 (20 mM) or DRB (20 mM) was added 2 h prior to nocodazole treatment. Cell lysates were then prepared and histone H1 phosphotransferase activities were measured. (b) cdc2 activity is downstream to CK2 and p38 MAPK. Proteins were immunoprecipitated with anti-cdc2 antibody and its phosphotransferase activity was assayed toward histone H1. (c) Activation of CK2 in nocodazole-arrested cells is dependent on p38 MAP kinase. CK2 protein in cell lysates, prepared from the above treatment, was immunoprecipitated with monoclonal antiCK2a antibody and assayed for phosphotransferase activity towards the CK2 speci®c substrate RRADDSDDDDD. The lower panel shows equal amounts of CK2 protein were immunoprecipitated. (d) CK2 is the major kinase phosphorylating p53 at serine 392, Cell lysates from the above treatment were immunoblotted with phospho antibodies to p53 (serine 392) and p38a. (e) p38 protein was immunoprecipitated with anti-p38a antibody and assayed for phosphotransferase activity toward activating transcription factor 2 (ATF2). The lower panel shows equal amount of p38 protein was immunoprecipitated. All of these speci®c inhibitor SB 203580. (Whereas a suppression of p53 phosphorylation was observed using DRB, no change was found with CK2 sense oligonucleotide, data not shown). This eect was independent of changes in p53 protein expression (lower panel). The depletion of CK2 did not aect the phosphorylation or the activation of p38 upon nocodazole treatment (Figure 2d ,e), con®rming its role downstream of p38 MAPK activation. Thus, these results indicate that CK2 phosphorylates p53 at serine 392, due to the nocodazole-induced activation of the spindle assembly checkpoint, and p38 MAPK is its upstream regulator.
It should be noted that HeLa cells are known to harbor human papilloma virus (HPV), which has been shown to target p53 for degradation (Schener et al., 1993) . However, it has been reported that cervical carcinoma cells, including HeLa, express functional wild-type p53, which is sucient to activate the transcription of cellular target genes (Butz et al., 1995 (Butz et al., , 1999 . The level of p53 expression observed in our studies is consistent with this ( Figure 2d ). Furthermore, we have measured the expression of p53-stimulated p21 WAF1 protein in HeLa cells treated with dierent genotoxic stresses to con®rm that it is indeed functional (results not shown).
Depletion of CK2 compromises mitotic arrest following spindle damage
Having demonstrated an eect of CK2 depletion on mitotic arrest (Figure 1 ), cyclin B/cdc2 kinase activity and p53 phosphorylation (Figure 2) , we wanted to determine the cell cycle characteristics of these cells in more detail. Therefore, exponentially growing HeLa cells were transfected with CK2 AS, S or buer alone. Cells were then synchronized in G1 phase by serum deprivation (0.5%) for 30 h and then released into the cell cycle by the addition of 10% serum containing medium. Nocodazole was added before the cells entered mitosis for the indicated times shown (Figure 3a) . The FACS analysis data for synchronized cells showed DNA content of 75% of cells with 2N and 9% accumulated 4N populations (data not shown). After 6 h following release into the cell cycle, cells progressed through S phase and entered G2 and mitosis with similar kinetics (Figure 3a) . However, from 12 h, the behavior of these populations was dramatically dierent. AS-treated cells (control), S-or buer-treated cells continued to accumulate in mitosis for the next 12 h with DNA content of 4N. The time-dependent increase of cdc2 activity (Figure 3b ), as well as corresponding cyclin B expression (Figure 3c ), and mitotic index (Figure 4b ) by 18 h, all con®rm that these cells remained blocked in mitosis upon exposure to nocodazole. Signi®cantly, cells devoid of CK2 appeared to progress into the cell cycle, compromising the mitotic block (Figure 3a) , with a large population of cells progressing into a G1-like state with DNA content of 2N populations by 24 h. The mitotic index (Figure 4b ) of the cycling cells indicates that 530% of cells entered mitosis by 24 h, despite disruption of mitotic assembly. Thus, CK2-depleted cells treated with nocodazole appeared to exhibit an override of the mitotic assembly checkpoint and an apparent reentry into S phase. This was also manifested by an alteration of cyclin B expression ( Figure 3c ) and cdc2 inactivation (Figure 3b ).
To further investigate if the expression of cyclin B was correlated with phosphorylation-dependent inactivation of cdc2, the electrophoretic mobility of cdc2 was used to assess whether it was phosphorylated on threonine 14, tyrosine 15 or both. Figure 3d shows the phosphorylation stages of cdc2 upon nocodazole stimulation in the presence and absence of CK2 antisense. The most gel-retarded form of cdc2, species a', is phosphorylated on both threonine 14 and tyrosine 15 whereas the intermediate form, species`b', is phosphorylated on threonine 14 or tyrosine 15, but not both. The fastest migrating form of cdc2 (species c') is not phosphorylated on either threonine 14 or tyrosine 15, and represents either the active form of the kinase (phosphorylated on threonine 161 and bound to cyclin B), or cdc2 that is not bound to cyclin (monomeric, inactive cdc2) (Atherton-Fessler et al., 1994; Liu et al., 1997) . These results were con®rmed by using the phospho-speci®c anti-cdc2 tyrosine 15 antibody (results not shown). Figure 3d demonstrates that the phosphorylation state of cdc2 remains unchanged in AS-transfected cells, whereas cyclin B turnover is altered (Figure 3c ). Collectively, these results indicate that the inhibition of cdc2 activation in CK2-depleted cells upon nocodazole exposure, was not correlated with changes in the phosphorylation of cdc2, but was likely due to the altered cyclin B kinetics. Similar results were also obtained by using the CK2 inhibitor, DRB (data not shown).
Mitotic spindle checkpoint compromise requires p53 protein p53 has been shown to be involved in G2/M phase to maintain cell diploidy (reviewed in Ko and Prives, 1996) . Several studies have shown that p53 7/7 cells accumulate 4N, 8N and 16N populations upon exposure to microtubule inhibitors for 448 h (Cross et al., 1995; Di Leonardo et al., 1997; Lanni and Jacks, 1998) . From our ®ndings thus far, we were unable to directly implicate p53 in the altered spindle checkpoint arrest observed following CK2 depletion. Therefore, we investigated this hypothesis in the colorectal MIN (microsatellite instability) HCT116 cancer cell line, because it has an intact spindle-dependent checkpoint (Bunz et al., 1998) . As expected, HCT116 cells with either wild-type (wt) p53 +/+ or with disrupted p53
alleles, were shown to arrest in M phase upon nocodazole exposure (Figure 4a ). However, p53 (Figure 4b ), accumulating 4N with diminished 2N populations (Figure 4a) . Thus, it appeared that the normal checkpoint status of MIN cells following CK2 depletion and spindle damage, is converted to that characteristic of CIN (chromosomal instability) cells (Cahill et al., 1998) .
We evaluated whether cyclin B expression was aected in p53 7/7 cells. Figure 4c shows that cyclin B was not aected by depletion of CK2. These ®ndings argue against an impairment of cyclin B expression, as being responsible for the failure to transgress the spindle checkpoint. The p53 +/+ cells exhibited a down-regulation of cyclin B expression in response to antisense CK2 depletion in keeping with the HeLa cell data.
Another important ®nding to emerge from investigation of the HCT116 cells was that antisense depletion of CK2 did not in¯uence the ability of the cells to reach the mitotic checkpoint. This is exempli®ed by the fact that both at 18 h and at 24 h, there are equivalent fractions of cells at the G2/M stage for both nocodazole, and nocodazole+antisense treated p53
7/7
Figure 3 Mitotic arrest is compromised in the absence of CK2. (a) Synchronized HeLa cells (in G0), treated with CK2 antisense or sense, were released into cell cycle and collected for¯ow cytometric analysis in the presence and absence of nocodazole (200 ng/ml) at the indicated time. Lysates from the above treated cells were immunoprecipitated with anti-cdc2 antibody and assayed for cdc2 phosphotransferase activity (b) or either subjected to immunoblotting with anti-cyclin B (c) or cdc2 (d) protein. This experiment was cells (60 and 61% at 18 h, and 67 and 65% at 24 h respectively). Moreover, this reduces the possibility that AS treated HeLa cells underwent a G1 or S phase delay. Furthermore, our data indicated that neither the activity nor the protein levels of CK2 were aected in HCT116 p53
7/7 cells (results not shown). Therefore, these studies seem to indicate that abrogation of the mitotic assembly checkpoint and cyclin B degradation are dependent on p53 protein, and in addition, are regulated by CK2.
Cells transfected with CK2 antisense escaped nocodazole-induced cell death
The tumor suppressor p53 has been shown to mediate apoptosis in several cell types. Loss of p53 prevents thymocytes from undergoing apoptosis after gamma irradiation, and decreases the ecacy of chemotherapy in vitro, and in vivo (Clarke et al., 1993; Lowe et al., 1993 ; reviewed in Ko and Prives, 1996) . To examine cell death in cells transfected with CK2 AS, we analysed and quanti®ed the phenotypic changes characteristic of apoptotic cells by double staining HeLa cells with annexin V and propidium iodide (PI). Exponentially growing control or AS-transfected cells were exposed to nocodazole, and then harvested every 6 h. Figure 5a shows that 22% of control cells had undergone apoptosis (lower right panel) after 24 h of exposure with nocodazole. These observations are consistent with previous studies in certain cell lines, which undergo apoptosis following persistent exposure to nocodazole (Minn et al., 1996; Taylor and McKeon, 1997) . In contrast, cells transfected with CK2 AS showed a signi®cant, reproducible 50% reduction in apoptosis. An even greater reduction in apoptosis (72%) consequent upon CK2 depletion was observed using HCT116 p53 +/+ cells (Figure 5b ). However, HCT116 p53 7/7 cells transfected with CK2 AS and exposed to nocodazole, demonstrated no change in the percentage of apoptotic cell fractions ( Figure 5c ). As expected, these cells exhibited a much lower frequency of apoptosis in response to nocodazole in comparison to p53 +/+ cells (10 vs 32.2%). In further support of cooperativity between CK2 and p53, it is apparent from this data that p53 7/7 cells do not exhibit a reduction of apoptotic cell fraction upon CK2 depletion.
Discussion
In this study we have demonstrated for the ®rst time, a functional co-operation between protein kinase CK2 and p53, in modulation of cdc2 kinase activity and the mitotic checkpoint arrest following nocodazole-induced spindle damage. This eect was in¯uenced by the p38 MAPK, as both the biochemical events and the cellcycle changes could be reversed using the p38 MAPK speci®c inhibitor, SB203580. Nocodazole-induced CK2 activation correlated with increased levels of cyclin B expression and cell cycle arrest, whereas the compromised checkpoint was associated with a reduction in levels of cyclin B and consequently a reduction in cdc2 activation. The latter event was shown to be dependent upon p53. The reduction in apoptosis exhibited by CK2 depleted cells, accompanied by the signi®cantly reduced mitotic index provides the strongest support for the notion that the mitotic checkpoint arrest was breached. The identical cell cycle distribution pattern observed for both nocodazole-treated and AS CK2-depleted p53 The C-terminal domain of p53 is a target for CK2 phosphorylation. It has been shown that CK2 and p53 associate in vivo via the binding of the regulatory b subunit of CK2 to the C-terminal domain of p53 (Appel et al., 1995; Gotz et al., 1999) . The eect of this phosphorylation upon the growth suppressing and transactivating activities of p53 is controversial (Hupp et al., 1992; Mundt et al., 1997; Rolley and Milner, . Most of the studies support a growth suppressing eect that is dependent on DNA binding (reviewed in Prives and Hall, 1999 ). An intriguing study by Hao et al. (1996) observed that whilst wildtype p53 is inactive in G1-arrested cells, it became activated by mutation of the murine CK2 site to glutamic acid. Mutation of the same site to alanine led to a restricted ability of p53 to repress the SV40 promotor, whilst leaving unaected the p21 (and RGC) promotors. In our study, using two dierent tumor cell lines, HeLa and colon cancer HCT116 cells, it was shown that p53's function during M phase, was dependent on the direct eect of CK2 on p53, following spindle damage. Previously, p53 has been demonstrated to prohibit re-duplication of DNA (Notterman et al., 1998) without completion of mitosis. Collectively, taken in context with previous observations, our results suggest a novel role of CK2 in concert with p53 protein to prohibit further DNA reduplication in response to spindle damage. The question remained as to whether the compromised mitotic arrest, observed in the absence of CK2, might be due to p53-mediated, abrogated expression of cyclin B. p53 regulates cell cycle checkpoints in response to genotoxic stress by targeting the transcription of speci®c gene that inhibit cyclin, cyclin-dependent kinase complexes. For example, at the G2/M checkpoint, there are several such genes, which include 14-3-3s (Hermeking et al., 1997; Chan et al., 1999) , GADD45 (Zhan et al., 1999) and B99 (Utrera et al., 1998) . In the example of 14-3-3s, G2 arrest occurs through the binding of cdc25C phosphatase and the resulting inhibition of activation of cdc2. This explanation is clearly inadequate, as cells de®cient in p53 are equally able to enter into G2 arrest following DNA damage. Additionally, it has also been shown that p53 can directly regulate cyclin B expression by lowering the intracellular levels of cyclin B protein (Innocente et al., 1999) . Therefore, we determined cdc2/ cyclin B activity in a cell line de®cient for p53 (p53
). Indeed, we found that neither phosphorylation of cdc2 (data not shown) nor degradation of cyclin B (Figure 4c) were aected in the HCT116 p53 7/7 cell line (in contrast to p53 +/+ cells), in the absence or inhibition of CK2, during persistent activation of the mitotic spindle checkpoint by nocodazole. This supports our hypothesis, that p53 functions to repress cyclin B expression. Similar ®ndings have been reported in normal human foreskin ®broblasts (HFFs), where p53 depletion (by transduction with human papillomavirus type E6) was associated with prolonged G2 arrest, in association with high levels of cyclin B/cdc2 kinase activity (Passalaris et al., 1999) . Furthermore, HeLa cells expressing a constitutively active cdc2 mutant (CDC2AF), and also exhibiting increased levels of cyclin B/cdc2 kinase activity, were also able to arrest in G2 (Jin et al., 1996) . In direct agreement with these observations, our cell cycle analysis data showed that cells lacking functional p53 underwent mitotic delay for up to 24 h (Figure 4) . Although it has been demonstrated that p53 does not aect the initiation, duration or magnitude of the mitotic delay following disruption of the mitotic spindle, in ®broblasts, it is an essential element of the mitotic checkpoint which prohibits re-duplication of DNA (Notterman et al., 1998) . It has been reported that p53 possesses checkpoint regulatory activity following nocodazole treatment (Lanni and Jacks, 1998) , speci®cally, to prevent S phase re-entry following adaptation from mitotic arrest by inducing p53-dependent arrest in 4N adapted cells. Signi®cantly, our observations in epithelial cells of two dierent origins, extend these ®ndings by implicating for the ®rst time, CK2 in this response. We therefore propose that the depletion of CK2, which correlated with suppression of p53 protein phosphorylation at serine 392, may confer upon p53 the ability to compromise the spindle checkpoint arrest, as a result of facilitating cyclin B degradation. Previous work has shown that mutation of p53 protein at the CK2 phosphorylation site (serine 392) inhibited the ability of p53 to cause growth repression but had no eect on its transactivation activity (Hall et al., 1996) . It has also been suggested that p53 can exist in a con®guration which might be inhibited for DNA binding but might remain active for other functions (reviewed in Ko and Prives, 1996) . This is further supported by the wellaccepted role for p53 transrepression in the induction of apoptosis (reviewed in Vogt Sionov and Haupt, 1999) . Thus, our results support a model in which p53 may lose the ability to maintain mitotic integrity, in the absence or dysfunction of CK2, by a loss of its ability to appropriately regulate cyclin B levels, as well as an inability to execute apoptosis.
Protein kinase CK2 activity is elevated in a multitude of human cancer cells including leukemias and solid tumors (Pinna and Meggio, 1997; Xu et al., 1999) . Although the precise signi®cance of this remains unknown, Landesman-Bollag et al. (1998) have demonstrated that misexpression of CK2a contributes to the loss of p53 alleles. We hypothesize that misexpression of CK2a, a common observation in most tumors (Allende and Allende, 1995) may have a role in compromising genomic stability, by impairing the appropriate response to spindle damage.
In conclusion, we propose a mechanistic signaling pathway that may regulate p53 in response to spindle damage. Upon microtubule disruption, p38 MAPK is activated and associates with CK2, regulating CK2's activity. In addition, it also modulates the phosphorylation of p53, modifying p53's function to ensure maintenance of genomic mitotic arrest. This is shown to be due at least in part through regulation of cyclin B/cdc2 kinase activity levels and subsequent induction of apoptosis.
Materials and methods
Cell culture and synchronization
HeLa and HCT116 (p53 +/+ and p53
, kindly donated by Dr B Vogelstein) were grown for 3 days until near con¯uency at 378C and 5% CO 2 on 175 cm 2¯a sks in 10% fetal calf serum (FCS) supplemented DMEM and McCoy's medium (GIBCO) respectively. Cells were split at 5610 5 cells /10 cm 2 dish 24 h prior treatment. For cell synchronization at G1/S phase, HeLa Oncogene Involvement of CK2 in spindle damage M Sayed et al cells were treated with double thymidine block (two 16 h periods of exposure to 2 mM thymidine separated by a 10 h exposure without thymidine). The cells were then rinsed twice with phosphate buer saline (PBS) and cultured in complete growth medium. Nocodazole (100 ± 400 ng/ml) or was added to either exponentially growing cells for the indicated times or to G1/S synchronized cells for 10 h. In some experiments HeLa cells were cultured in DMEM containing FCS (0.5%) for 30 h to synchronize cells in G0 phase, fresh DMEM supplemented with 10% FCS was then added to induce the cells to re-enter the cell cycle. After 18 h, nocodazole (400 ng/ ml) was added before cells entered M phase, as described (Takenaka et al., 1998) . Mitotic cells were collected by mechanical shake o, 9 h after release from thymidine block (G1/S) or 22 ± 26 h from G0 release (Takenaka et al., 1998) . In some experiments, the potent and speci®c CK2 or p38 MAPK inhibitors;
5,6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB) (20 mM) and SB203580 (20 mM) (Calbiochem) respectively, were used 2 h prior to the addition of nocodazole.
Oligonucleotide transfection
Cells were grown in medium containing FCS (0.5%) for 24 h prior to transfection, washed twice with PBS and supplemented with fresh medium containing 10% FCS. CK2a-a' antisense or sense oligonucleotide (2 mg/ml) was transfected into cells using Eectene (Qiagen) according to the manufacturer's protocol. CK2a-a' antisense and sense were designed as previously described (Ulloa et al., 1993) , with a modi®cation in which the entire oligonucleotides were phosphorothioated. Sequence: antisense (5' to 3'): GTA ATC ATC TTG ATT ACC CCA or sense (5' to 3'): TGG GGT AAT CAA GAT GAT TAC. Cells were incubated for 18 ± 24 h prior to any treatment.
Flow cytometry
Cells were trypsinized, washed with PBS and ®xed with 70% ethanol at the indicated time points then stored at 7208C. The ®xed cells were then stained with propidium iodide (50 mg/ml) with RNase (10 mg/ml). The stained cells were analysed for DNA content by¯uorescence-activated cell sorting (FACS) in a FACScan (Becton Dickinson Instruments). The forward and side scatter gates were set to exclude any dead cells from the analysis; 10 000 events within this gate were acquired per sample.
Western blotting
Adherent cells were washed twice with ice-cold PBS, scraped, then lysed in 50 mM HEPES (pH 7.2), 100 mM NaCl, 1 mM EGTA, 20 mM NaF, 1% Non-idet P-40, 1 mM sodium orthovanadate, 1% aprotinin, 1 mM phenylmethylsulfonyluoride, 1 mM pepstatin, 0.5 mg/ml leupeptin and 10 mg/ml soybean trypsin inhibitor. Lysates were subjected to brief sonication for 2610 s, centrifuged at 15 000 r.p.m. for 5 min, and the supernatants were collected and stored frozen prior to use. The protein concentration was determined by the method of Bradford using bovine serum albumin as the standard. Between 20 ± 50 mg of total cell lysate protein was loaded on sodium dodecyl sulfate (SDS) 712%, 37.5 : 1 polyacrylamide gel; 15%, 150 : 1 polyacrylamide gel was used for gel shift assay. Western blot analyses were performed with mouse monoclonal; anti-human cyclin B1 (Pharmingen), antip53 (StressGen), phospho-p53 ser-392, phospho-cdc2 (New England Biolabs), and CK2a (kindly donated by Dr OlafGeorg Issinger). Rabbit polyclonal anti-p34 cdc2 (Kinetek Pharmaceuticals), phospho-p38a, (New England Biolabs) and p38a (Santa-Cruz) antibodies, were also used.
Protein kinase assays
Immunoprecipitations were performed by incubating 500 mg of whole lysate with 4 mg with anti-CK2a, or cdc2, or p38 MAPK and 20 ml of protein A-Sepharose (preblocked with 1% BSA) for 3 ± 4 h at 48C. The beads were washed four times with 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40 and the above protease and phosphatase inhibitors. For immune-complex kinase assays, the immunoprecipitated beads were washed one additional time with buer A (12 mM MOPS (pH 7.2) and 15 mM MgCl 2 ), and incubated with either 5 mg of the speci®c CK2 substrate RRADDSDDDDD (Calbiochem) or with H1-histone (for cdc2), or ATF2 (for p38 MAPK), in a ®nal volume of 25 ml with 5 or 10 mCi of 100 mM [g-32 P]ATP in buer A, for 10 min at 308C. Reactions were stopped by either spotting 20 ml onto 1.5 cm 2 piece of Whatman P-81 phosphocellulose paper and the incorporated radioactivity was measured in Wallec (LKB) scintillation counter, or by the addition of SDS ± PAGE sample buer. After boiling, the samples were subjected to SDS ± PAGE for autoradiography with X-ray ®lm or by immunoblotting analysis.
Mitotic index
Cells were collected by incubation with trypsin containing EDTA, centrifuged, counted for normalization and then ®xed in a solution containing 3.7% formaldehyde, 0.5% NP-40 and Hoescht 33258 (10 mg/ml) in PBS. Nuclei were visualized by¯uorescent microscopy. Nuclei with condensed, evenly stained chromosomes were scored as mitotic. At least 600 cells were counted for each determination.
Apoptosis assay
Cells were collected at the indicated time points by incubation with trypsin-EDTA, centrifuged and washed twice with ice-cold PBS, then stained with Annexin-V FITC and propidium iodide (PI) according to the manufacturer's protocol (Pharmingen). Cells were analysed using the CellQuest software on a Becton Dickinson FACScan and 10 000 events were acquired per sample.
